Pipeline Previews

By No Comments
FDA Boxed Warning for TygacilThe FDA is warning that an analysis shows an increased risk of death when intravenous (IV) Tygacil (tigecycline) is used for FDAapproved uses as well as…
Read More

Clinical Trial Review

By No Comments
A Phase 3, Prospective, Open-Label, Multicenter Study of Lymphoseek Sponsored by Navidea Biopharmaceuticals, the purpose of this study is to determine the false negative rate (FNR) associated with Lymphoseek-identified sentinel…
Read More